Qube Research & Technologies (QRT)’s iBio IBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Hold
0
-$1 4511
2023
Q3
Hold
0
4036
2022
Q4
Sell
-322
Closed -$27K 2706
2022
Q3
$27K Sell
322
-36
-10% -$4.96K ﹤0.01% 2253
2022
Q2
$47K Buy
+358
New +$53.8K ﹤0.01% 2137
2022
Q1
Sell
-435
Closed -$120K 2694
2021
Q4
$120K Buy
+435
New +$166K ﹤0.01% 2101

Other funds holding IBIO

Qube Research & Technologies (QRT)'s IBIO Position: Q4 2023 in Review

Qube Research & Technologies (QRT) held its iBio (IBIO) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4511.

Qube Research & Technologies (QRT) first reported a position in IBIO in Q4 2021 and has held it in 3 quarters since. The position peaked at $120K in Q4 2021. 21 funds tracked by Wall St. Rank hold IBIO as of Q4 2023.

  • Qube Research & Technologies (QRT) held 0 shares of iBio worth $0 as of Q4 2023.
  • Qube Research & Technologies (QRT) left its iBio share count unchanged in Q4 2023.
  • iBio made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q4 2023, its #4511 holding.
  • Qube Research & Technologies (QRT) first reported a position in iBio in Q4 2021 and has held it in 3 quarters since.
  • Qube Research & Technologies (QRT)'s iBio position peaked at $120K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held iBio as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.